One of the most exciting, and significant, technological advances of our time, is in the biotechnology and health sphere. For this reason, it was with interest that we recently attended an event, held by Roche Diagnostics South Africa.

There they launched two new laboratory products, and also announced that they have expanded Roche’s Coagulation testing offering.

This, as laboratories respond to growing demand for timely, reliable results to support emergency medicine, surgery, critical care, and the ongoing management of patients with bleeding or clotting disorders.

Coagulation testing can help laboratory analysts and doctors assess unexplained bleeding, investigate suspected clotting disorders, monitor anticoagulant treatment and respond to urgent conditions in which delays may affect care.

The company explained that as testing volumes increase and patient pathways become more complex, laboratories are under pressure to deliver accurate results while making the best use of highly specialised staff.

New automation innovations can reduce repetitive manual processes, improve standardisation and support more consistent workflows without removing the judgement and expertise of laboratory professionals.

Coagulation innovation that supports laboratory expertise

Modern coagulation workflows automate steps that have traditionally required significant hands-on time, including reagent preparation, sample checks, quality processes and routine maintenance. This helps reduce avoidable errors and allows laboratory teams to direct more attention to complex testing, interpretation and clinical collaboration.

The operational excellence this system provides can also support continuity during busy periods by enabling laboratories to manage samples and reagents while testing is underway. A streamlined workflow coupled with automated reagent preparation and advanced instrument checks enables laboratories to focus on other laboratory tasks while the instrument is operational in the background.

“Coagulation testing supports clinical decisions across many areas of healthcare, from surgery and emergency care to the monitoring of patients receiving anticoagulant treatment. As testing demands increase, laboratories need workflows that are standardised, efficient and able to connect smoothly with the wider laboratory environment,’’ explained Mamello Moahloli, Product Manager at Roche Diagnostics South Africa.

“Automated and standardised processes can reduce repetitive manual steps and help laboratory professionals to focus their expertise where it adds the most value. For patients, this means supporting the timely, reliable results clinicians depend on when making decisions about their care,” she continued.

The value of integrated laboratory systems

Integrated laboratory systems support simultaneous testing across multiple disease areas, smoother sample movement, more consistent data transfer and closer alignment among instruments, laboratory information systems, and quality processes.

This matters, Roche explained, because a laboratory result is part of a broader patient journey. Efficient sample handling and reliable data flow can help reduce avoidable delays between testing and the clinical decisions that follow. Integration also gives laboratories greater flexibility to standardise processes across sites and plan for changing service needs.

From laboratory workflow to patient care

For patients, the benefit of improved laboratory workflow is indirect but important. Timely, reliable coagulation results can support decisions about surgery, anticoagulant treatment, emergency intervention and the investigation of bleeding or thrombotic conditions. They can also help clinicians determine when further testing or imaging is necessary.

The company explained that the expansion builds on Roche’s long-standing work in diagnostics and its broader focus on laboratory systems that support consistent testing, connected workflows and informed clinical decision-making.

And, while the launch of the new innovations will affect laboratories directly, better health outcomes affect everyone.